Ai Viral
Paid
Indie SaaS founders shipping with tools like Lovable or Cursor
Most retail investors either drown in a dozen open browser tabs — earnings call transcripts, Reddit threads, analyst notes, price charts — or they skip the research entirely and buy on a hunch. AlphaVue is built for the gap between those two failure modes.
$9.90/mo or $99.00/yr · Free tier: Core AI stock analysis, Limited monthly analyses, Basic watchlist, One monthly Strategy Lab run and Forward Test · Checked Oct 21, 2026
The tool runs 20+ agents in parallel — market, earnings, news, and sentiment specialists — then forces them into a structured bull-versus-bear debate before delivering a single BUY / HOLD / SELL verdict with a confidence score and risk tier. The full workflow completes in roughly two minutes, the vendor states, covering 50,000+ tickers across 70+ global markets. Where it fits cleanly: a retail investor who wants a structured first-pass on a new ticker without spending an hour doing it manually. Where it strains: the free tier caps monthly analyses at 15, email alerts are a paid-only feature, and the thesis change log on the free plan rolls off after seven days — so ongoing portfolio monitoring is functionally paywalled.
Bottom line: Run this when you want a fast, evidence-backed first look at an unfamiliar stock; hit the ceiling when you're monitoring more than ten positions and need alerts, because both email notifications and meaningful thesis history require a paid upgrade.
For first-time users who want to explore AlphaVue
For active investors who need persistent tracking, alerts, and daily briefs
For active investors who need persistent tracking, alerts, and daily briefs. Save 17%
View full pricing on alphavue.ai →
Pricing may have changed since last verified. Check the official site for current plans.
Find your fit
More options in Business. Compare pricing, platforms, and features side by side.
Paid
Indie SaaS founders shipping with tools like Lovable or Cursor
Freemium
Marketing teams running social ad campaigns
AlphaVue is a web application that takes a stock ticker and returns a structured investment research report without requiring the user to source any data themselves. The agent pipeline runs in four sequential stages: four agents collect independent data on price and volume, earnings and valuation, news catalysts, and market sentiment simultaneously; those outputs are then fed into a cross-examination debate; a three-perspective risk check follows (described as aggressive, neutral, and conservative stances); and finally a single verdict is output with a confidence percentage and a hold window. The vendor states the full cycle typically completes in a few minutes.
The standout feature is the bull-versus-bear debate layer baked into every report. Rather than summarizing only the positive case — which is the failure mode of most AI-generated stock summaries — AlphaVue’s agents are explicitly tasked with generating counterarguments. The NVDA sample report on the product page shows this concretely: bull points on GPU demand and CUDA ecosystem lock-in sit directly alongside bear points on export restrictions and valuation multiples. Every conclusion is traceable to a cited source, which is what separates the output from a generic chat response.
The tool fits retail investors who want structured research on demand and are comfortable with a verdict-plus-evidence format. It does not expose an API, so teams wanting to pull verdicts into their own dashboards or automate batch analysis across a portfolio have no path to do that through AlphaVue. There is no self-hosted option. On the free tier, analyses are capped monthly, watchlist slots are limited, email alerts do not work at all, and thesis change history resets after seven days — meaning the continuous monitoring the product emphasizes is available in practice only to paid subscribers. Users who need to track more than a handful of positions will find the free tier exhausted quickly.
Sign in to rate this tool or suggest an edit.